「out」の検索結果
40件：1～5件目を表示
-
156_mirai_outline.indd
https://www.senju.co.jp/medical/magazin/pdf/mirai/156.pdf -
ルミガン点眼液0.03％
001) 23.7±6.87 (＜0.0001) 平均値±標準偏差 a）Dunnettの多重比較 ― 15 ― また、 プラセボの平均眼圧変化量である２mmHg以上の眼圧下降を示した被験者の割 合及びOutflow pressure下降率が20％以上の被験者の割合を追加解析として算出 した結果、0.03％及び0.1％ビマトプロスト点眼液では８日後、15日後ともにいず れの割合も100％であったのに...
https://www.senju.co.jp/sites/default/files/2020-09/RM_IF.pdf -
aim of obtaining manufacturing and marketing approval. The development of SJP-0008 is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708.pdf -
ith the aim of obtaining manufacturing and marketing approval. This clinical trial is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by...
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509.pdf -
ith the aim of obtaining manufacturing and marketing approval. This clinical trial is to be carried out with funding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by...
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509_0.pdf